recurrent mantle cell lymphoma
Showing NaN - NaN of 1
Recurrent Mantle Cell Lymphoma Trial in United States (Bortezomib, Laboratory Biomarker Analysis, Lenalidomide)
Completed
- Recurrent Mantle Cell Lymphoma
- Bortezomib
- +2 more
-
Anaheim, California
- +81 more
Oct 2, 2018